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Abstract:  
Unconjugated bilirubin (UCB) is produced mostly in the spleen from the 
turnover of heme. UCB is conjugated by the activity of hepatic UGT1A1enzyme 
(UDP-glucuronosyltransferase 1A1) and exported into the bile. High serum level 
of UCB is toxic to cells, and its intracellular accumulation is suggested to be 
limited by multidrug resistance proteins 1 and 3 (MRP1 and MRP3) that export 
UCB out of the cells to prevent its toxicity. In this study, the expression profile 
for MRP1 and MRP3 was analysed by qRT-PCR and Western blot in the liver 
and the spleen of two animal models of hyperbilirubinemia (β-thalassemic mouse 
and Gunn rat). The results indicated that MRP1 mRNA and protein expression 
remained unchanged in the liver and spleen of both animal models. MRP3 
mRNA and protein are up-regulated in the spleen of β-thalassemic mouse and 
liver of Gunn rat. In conclusion, high level of UCB induces only the expression 
of MRP3 which may indicate its possible role in preventing UCB toxicity. 
Keywords: Multidrug resistance-associated proteins, hyperbilirubinemia, β-
thalassemia, Gunn rat. 
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 الملخص:
ر جزيء الهيم الموجود في الهيموغلوبين يتنتج عن تكسالبيليروبين غير المباشر هي مادة صفراء اللون 
 dna I esnegyxo emeH( نتيجة نشاط إنزيمان هما:  ،المكوِّ ن  لكريات الّدم الحمراء في الطحال
فإنها  ،نظرا ولأن مادة البيليروبين غير المباشر هي مادة غير ذائبة في الماء ،)esatcuder nidreviliB
وهكذا يتحّول  ،)1A1TGU(بواسطة الإنزيم   )dica cinoiruculG(مع حمضتنتقل إلى الكبد وتتّحد 
 والذي يتخلّص منه الجسم عن طريق القنوات الصفراء. ،الى البيليروبين المباشر الذائب في الماء
كما هو  ،قد تؤّدي بعض الحالات إلى إرتفاع نسبة البيليروبين غير المباشر في الدم عن مستوياته الطبيعية 
عندما ترتفع نسبة البيليروبين في الأيام الأولى  ،)ecidnuaj latanoen(ل في اليرقان الفسيولوجي الحا
فسيولوجي مهم لحماية خلايا بعد الولاده مباشرة قبل أن تعود الى مستوياتها الطبيعية. هذا الإرتفاع ال
هناك  ،لإلتهابات. في المقابلحيث تعتبر مادة البيليروبين من المواد القوية المضادة للأكسدة وا ،الجسم
-β(بعض الحالات الّتي ترتفع فيها نسبة مادة البيليروبين بشكل كبير كما هو الحال مثلا في 
حيث يؤدي تكسير كريات الّدم الحمراء باستمرار إلى إرتفاع نسبة البيليروبين غير  ،)aimessalahT
 1A1TGU(حيث يؤدي غياب الانزيم ( ،)I epyT mordnyS rajjaN relgirC(ومتلازمة  ،المباشر
الى تراكم البيليروبين غير المباشر في الّدم. هذا الإرتفاع الكبير في مادة البيليروبين غير المباشر يحفّز 
خاّصة الخلايا العصبيّة حيث يؤّدي إلى اليرقان النّووي  ،)sisotpopA(عملية الموت المبرمج للخلايا 
ما عدا خلايا  1A1TGU(. لأّن جميع خلايا الجسم لا تحتوي على إنزيم ()suretcinreK(والتّلف العقلي 
فإنّها تستخدم وسيلة أخرى للحفاظ على مستويات قليلة من البيليروبين غير المباشر داخلها. هناك  ،الكبد
لنّقل الكثير من الدراسات العلمية والتّجارب العمليّة على الخلايا والنّماذج الحيوانيّة ركّزت على دور ا
 في حماية الخلايا من سميّة مادة البيليروبين غير المباشر. )3PRM dna 1PRM(النّشط من خلال نواقل 
 dna RCP-TRq( بإستخدام  ،في هذه الدراسه العلمية قمنا بتحليل التعبير الجيني والبروتيني لهذه النواقل
لرئيسة المسؤولة عن عمليات أيض باعتبارهما الأعضاء ا ،في أنسجة الكبد والطحال  )tolb nretseW
 )tar nnuG dna esuom cimessalahT-β(.البليروبين في النّماذج الحيوانيّة 
لا تتّغير بارتفاع نسبة البيليروبين في الكبد  )1PRM(تشير النتائج إلى أّن التّعبير الجيني والبروتيني للناقل 
ؤّشر على الّدور المحدود لهذه المضّخات في حماية مّما ي ،والطحال لأي من النماذج الحيوانيه المدروسه 
في المقابل تشير النّتائج إلى أن البيليروبين غير المباشر يؤّدي  ،الخلايا من سميّة البيليروبين غير المباشر 
والطّحال  ،)tar nnuG(في الكبد للنّموذج الحيواني  )3PRM(إلى تحفيزالتّعبير الجيني والبروتيني للناقل 
مما يُدل على الّدور المهم لهذه المضّخات في حماية  ، )esuom cimessalahT-β(ج الحيواني للنموذ
 الخلايا من سميّة البيليروبين غير المباشر.  
 :noitcudortnI
 si noitadarged emeH .msilobatac emeh eht fo tcudorp dne evitadixo eht si niburiliB
 neht si hcihw nidrevilib gnicudorp ,I esanegyxo-emeh emyzne eht yb demrofrep
 ecnO .esatcuder nidrevilib eht yb )BCU( niburilib detagujnocnu ot detrevnoc
 tub ylthgit si BCU ,ytilibulos suoeuqa roop sti ot eud dna doolb eht ni desaeler
 detagujnoc si ti erehw revil eht otni derrefsnart dna nimubla ot sdnib ylbisrever
 )1A1TGU( 1A1 esarefsnartlysonoruculg-PDU emyzne eht yb dica cinoruculg htiw
 retropsnart 2PRM eht yb sulucilanac elib eht otni deterces yllanif dna
1
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UCB has a vital role under physiological and pathological conditions. Neonatal 
jaundice is characterised by mild serum UCB level "physiological 
hyperbilirubinemia", and the pigment plays an essential cytoprotective role by 
acting as a potent antioxidant and anti-inflammatory molecule 
2,3
. However,  when 
the plasma level of UCB have excessively elevated the unbound or free fractions 
(Bf) of the UCB increase and may cause cell toxicity through different molecular 
mechanisms that involved oxidative stress, ER stress, calcium signalling, 
inflammation and apoptosis 
4,5
. UCB elevation is associated with several 
conditions such as; low blood pH (acidosis), the  use of drugs that compete with 
UCB for binding to plasma albumin (e.g., sulfonamide), hyperhemolysis (e.g., β-
thalassemia), or defect in UGT1A1 activity (e.g., Crigler Najjar syndrome type I) 
6,7
. 
Unlike hepatocytes, all cells do not possess conjugation activity, and must, 
therefore, even oxidise or export UCB to prevent its toxicity. MRPs are family of 
ATP-binding cassette transporters (ABC transporters) that mediate the ATP-
dependent export of many physiological and xenobiotic compounds 
8,9
, including 
UCB 
10
. 
Early studies about a possible role of MRP1 in UCB transport revealed that UCB 
at clinically relevant concentration is a substrate for YCF1 and YLL015 
(homology to human MRP1 and MRP2, respectively) gene products of transporter 
mutants in Saccharomyces cerevisciae
11
. Pascolo et al. demonstrated that UCB 
undergoes ATP-dependent export from trophoblastic BeWo cells by MRP1
12
. 
Cultured mouse astrocytes rapidly up-regulated the expression of MRP1 when 
exposed to UCB 
13
. Furthermore, Using Mouse Embryo Fibroblasts (MEF) of 
MRP1 knockout mice (-/-) and their wild-type (+/+), Calligaris et al., added more 
evidence that MRP1 has a functional role in protecting cells from UCB toxicity 
14
. 
MRP3 share 58% of homology to MRP1 and studies showed it modulation by 
conjugated and unconjugated hyperbilirubinemia. Liver MRP3 is up-regulated in 
animal models of obstructive cholestasis and when the activity of MRP2 is absent 
as a compensatory mechanism in which the conjugated bilirubin and other 
substrates are exported from hepatocytes back to the bloodstream for renal 
excretion 
15,16
. In the liver of Gunn rats (the animal model of Crigler Najjar 
Syndrom type I), MRP3 is induced in response to high level of UCB 
17,18
. 
In the present study, the expression profile of MRP1 and MRP3 mRNA and 
protein was characterised in liver and spleen of two different models of 
hyperbilirubinemia; the β-thalassemic mouse with chronic hemolytic 
hyperbilirubinemia 
19
, and the Gunn rat with chronic non-hemolytic 
hyperbilirubinemia 
20
. 
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Materials and methods 
Animals and serum bilirubin measurement: The study plan was approved by the 
Local Committee for Care and Use of Laboratory Animals and all animals were 
received human care. Adult WT (C57BL/6J) and β-thalassemic mouse models 
(n=5 at six months age) were received from the Department of Clinical and 
Experimental Medicines, University of  Verona, Italy 
19
. Seventeen days old (P17) 
of Control (NN) and homozygous (jj) Gunn rats were born and raised in the animal 
facility of the University of Trieste (n=5)
20
. Under anaesthesia, animals were 
decapitated. The livers and spleens were removed rapidly, rinsed extensively with 
ice-cold PBS and then snap-frozen in ice and stored at -80°C. The blood was 
collected, and then the total serum bilirubin concentrations were measured by 
diazo-reaction (Boehringer–Mannheim Kit 1552414, Monza, Italy). 
Total RNA extraction and quantification: Total RNA was isolated from tissues 
using the TRI Reagent (Sigma, USA) following the manufacturer’s instructions. 
RNA concentration was obtained spectrophotometrically (Beckman Coulter, 
DU
®
730) from A260 measurements (A260/A280 ratio was between 1.7 and 2.1). 
The integrity of the sample was assessed with 1% agarose gel electrophoresis. 
Reverse Transcriptase and quantitative real-time PCR: The cDNA was obtained 
from 1µg of purified MMLV-derived reverse transcriptase system kit (iScript 
™cDNA Synthesis Kit, BioRad Laboratories, Hercules, CA, USA) following the 
manufacturer’s instructions. Reverse transcriptase was performed in a thermal 
cycler at 25 °C for 5 min, 45 °C for 30 min, and 85 °C for 5 min. cDNA was stored 
at -20 C. Real-Time quantitative PCR was performed with an iCycler IQ (BioRad 
Laboratories, Hercules, CA, USA).18S and GAPDH were used as an endogenous 
control to normalise the expression level of target genes. The primers were 
designed by using the software Beacon Designer 2.0 (PREMIER Biosoft 
International, Palo Alto, CA, USA). Primers used were listed in (Table 1). 
cDNA (25 ng) was amplified by PCR using primers for selected genes in separate 
wells with 1x iQ SYBR Green Supermix and 250nM gene-specific sense and 
antisense primers in a final volume of 25 µl for each well. The used iQ SYBR 
Green Supermix comprises of 100mM KCl, 40mM Tris–HCl, pH 8.4, 0.4mM each 
dNTP, 50 U/ml iTaq DNA polymerase, 6mM MgCl2, SYBR Green I, 20nM 
fluorescein, and stabilizers. The PCR was performed in 96-well plates, each 
sample was performed in triplicate, and a no-template control was included for 
each amplification as a negative control. The thermal cycler conditions consisted 
of 3 min at 95 °C and 40 cycles at 95 °C for 20 s, 60 °C for 20 s and 72 °C for 30 
s. In order to verify the specificity of the amplification, a melt-curve analysis was 
performed for; 1 min denaturation at 95 °C, 1 min annealing at 55 °C, and 80 
cycles of 0.5 °C increments (10 s each) beginning at 55 °C. Thel melt-curve 
4
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analysis was carried out immediately after the amplification protocol. Non-specific 
products of PCR were not found in any case. A standard curve was generated using 
a “calibrator” cDNA (chosen among the cDNA samples), which was serially 
diluted and analysed. The iCycle iQ Real-Time PCR Detection System Software 
generated the equation describing the plots of the log10 of the starting quantity 
(micromoles) of 5 dilutions (125, 25, 5, 1, and 0.2 ng) of the calibrator cDNA 
versus the corresponding threshold cycle. The efficiency of qRT-PCR of primer 
pairs was calculated with the following formula: 
Efficiency = [10 
(-1/slope)
] – 1  
To reduce the experimental variation, the results were normalised to 18S and 
GAPDH. The initial amount of the template of each sample was determined as 
relative expression versus one of the samples chosen as a reference (in this case the 
control sample) which is considered the 1x sample. Data were analysed using the 
Gene Expression analysis for iCycler V1.10 2004 (Bio-Rad). Briefly, for each set 
of replicates, the spreadsheet calculates the mean Ct and the standard deviation for 
the sample and derives a relative quantity from the equation: 
Relative quantity = efficiency 
(control Ct – unknown Ct)
 
Where the control Ct is the Ct of a sample chosen as a control, and the unknown Ct 
is the value of the sample of interest. The normalisation factor is calculated as the 
geometric mean of the relative quantities for all reference genes use: 
Normalization factor = (quant. ref.1* quant.ref.2*…* quant. ref.N) (1/N) 
The unscaled expression level for the sample of interest is calculated using the 
equation: 
Expression level = relative quantity/normalization factor 
Then a scaled value dividing the unscaled expression level of each sample by the 
unscaled expression level of the control sample is calculated. 
Protein extraction, quantification and SDS-PAGE: Liver and spleen tissues (50 
µg) were thawed and homogenised with 150µl of 10mM HEPES (pH 7.4), 
containing 0.2mM CaCl2 and 0.25M sucrose, using a tight Dounce–Potter device. 
Protein concentration was assessed spectrophotometrically with the bicinchoninic 
acid reaction with bovine serum albumin as standard 
21
. 
SDS–PAGE separated proteins homogenate containing loading dye with 10% ß-
mercaptoethanol in 10% acrylamide gel. Molecular weight standards 53-212 kDa 
(Amersham–Pharmacia, Buckinghamshire, UK) were used as marker proteins. The 
gel was run by electrophoresis as follow: 80V for stacking region and 180Vfor 
running region. Then, the gel was obtained and blotted onto a nitrocellulose 
membrane (PVDF) (Schleicher and Schuell, Dassel, Germany) with a wet blotting 
system (Sigma, St. Louis, MO, USA), using transfer solutions (700ml H2O, 200ml 
methanol 20%, and 100 ml transfer solution 10X) for 2 hour at 100V. After 
5
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transfer, the gel was checked by Coomassie blue and the PVDF membrane by red 
Ponceau. The membrane was washed three times with T-TBS (0.2% Tween 20; 
20mM Tris; and 500mM NaCl; pH 7.5) and blocked with the 4% milkT-TBS 
solution for 1 hour at room temperature. The primary antibodies were diluted with 
the same blocking solution and incubated overnight at 4°C (1:2000 dilution). Next 
day the primary antibodies were removed, the membrane was washed and 
incubated with secondary antibodies for 1 hour at room temperature (1:5000 
dilution). The peroxidase reaction was obtained by exposure of the membrane in 
the ECL-Plus Western Blotting detection system solutions (Amersham–
PharmaciaBiotech, UK). After transfer to Kodak film, the bands were visualised by 
Kodak EDAS 290 (Kodak instruments, New Haven, Ct, USA) using Kodak 1D 
images software. The images were taken in TIFF formats and transferred to the 
Scion Image program. The optical density of the target proteins was taken and 
normalised to α-actin and represented as protein relative expression (ratio). List of 
antibodies and conditions of incubation were summarised in (Table 2). 
Statistical analysis: Data are reported as means ± SD. The two-tailed Student “t-
test assessed differences between means”. The values considered significant when 
p<0.05 *, p<0.01 ** and p<0.001 ***. 
 
Results 
Total serum bilirubin levels in β-thalassemic mouse and Gunn rat 
TSB level was markedly elevated (6 folds) in β-thalassemic mouse compared to 
WT mouse, and in 17 days old jj Gunn rat (14 folds) compared to NN control rat 
(Table 3). 
MRP1 expression in the spleen of β-thalassemic mouse and liver of Gunn rat 
Spleenic MRP1 mRNA and protein expression were expressed equally in both WT 
and β-thalassemic mice (Figure 1A and 1B). Similarly, hepatic MRP1 mRNA and 
protein expression were not changed in jj Gunn rat compared to NN  control rat at 
17 days old (Figure 2A and 1B). 
MRP3 expression in the spleen of β-thalassemic mouse and liver of Gunn rat 
Spleenic MRP3 mRNA expression was up-regulated (5.5 folds) in ß-thalassemic 
mouse compared to WT mouse. MRP3 protein was undetectable in WT mouse 
while 100% induced in β-thalassemic mouse (Figure 3A and 3B). The C-18 
antibodies recognise the two bands for MRP3 protein  (Figure 3A), which is 
probably the differentially glycosylated forms that were recognised by different 
antibodies used in the previous study 
22
. Hepatic MRP3 mRNA and proteins were 
induced (3 folds and 2.5 folds, respectively) in jj Gunn rat than NN control rat 17 
days old (Figure 4A and 4B). 
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Discussion and conclusion 
Unconjugated bilirubin (UCB) is responsible for neonatal jaundice and at this 
physiological condition UCB has significant cytoprotective roles. UCB 
accumulates in organs and causes cytotoxicity especially for neurons due to high 
blood concentration
6
. Because UCB can diffuse into any cell type, all cells must 
maintain low intracellular concentration; this is regulated by consumption 
(conjugation and oxidation) and/or export of the UCB back to blood serum
10
. The 
liver is the only organ that can conjugate UCB by the UGT1A1 enzyme and 
therefore other cell types should oxidise or export UCB to prevent its toxicity.  
Previous studies focused on the possible role for MRP1 and MRP3 in exporting 
UCB out of the cells to prevent its intracellular toxicity. In vitro studies suggested 
that MRP1 might have a crucial role in protecting cells against UCB toxicity 
11–14
. 
However, many of the published in vitro findings may be irrelevant to the in vivo 
condition 
23
. Many factors may affect the in vitro studies such as the type of cell, 
species differences in the cellular systems employed, the length of exposure to 
UCB and cell age in culture. Several studies using in vivo and in vitro models also 
demonstrated an essential role for MRP3 in transporting UCB back to the 
bloodstream for renal excretion 
15,16,24
. 
In the present work, the mRNA and protein expression profile for MRP1 and 
MRP3 were analysed in vivo under two different conditions of hyperbilirubinemia 
which was confirmed by measuring the TSB levels (Table 3). Expression of both 
transporters was analysed in the spleen of the β-thalassemic mouse (chronic 
hemolysis - conjugated hyperbilirubinemia) and liver of Gunn rat (UGT1A1 
deficiency – unconjugated hyperbilirubinemia) because each organ (with its related 
animal model) is exposed to high level of UCB. 
In the spleen of the β-thalassemic mouse, qRT-PCR data and Western blot analysis 
indicated that UCB did not change the mRNA and protein expression of MRP1, 
while it induced the MRP3 mRNA expression (Figure 1 and 3). Similarly, in the 
liver of Gunn rat, MRP1 mRNA and protein expression were not changed, while 
MRP3 mRNA and protein levels were induced by UCB (Figure 2 and 4).  
The results obtained in both animal models showed that any form of 
hyperbilirubinemia does not modulate MRP1expression in vivo. Analysis of MRP1 
promoter constructs indicated that the promoter is TATA-less, CAAT-less and the 
GC rich may form the CpG island and suggested that MRP1 has a heavy promoter 
that makes this gene hardly to be induced under several conditions
25,26
. 
Furthermore, we cannot exclude any role for MRP1 (if any) in transporting UCB 
because the basal expression could be enough for its maximum transporting 
activity. Indeed, the mRNA basal expression for MRP1 is much higher than MRP3 
in both tissues (data not shown). 
7
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The results also indicated that UCB induced the mRNA and protein expression of 
MRP3 transporter and suggested its possible role in exporting UCB back to the 
bloodstream. The induction of MRP3 by UCB seems to be at transcriptional level. 
Indeed, MRP3 gene was suggested to be an inducible form among MRPs family, 
and it has a promoter construct with TATA-box, CAAT-box, and has several 
enhancer cis-elements 
27,28
. 
In conclusion, our in vivo study showed that the high level of UCB did not change 
MRP1 expression in the spleen of β-thalassemic mouse and liver of Gunn rat. 
MRP3 is induced in both organs exposed to high level of UCB. More in vitro 
experiments should be performed to analyse the direct role of MRP3 in preventing 
UCB toxicity 
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Table 1. Primer sequences of genes designed for quantitative real time-PCR 
Gene 
Name 
Accession 
number 
Forward primers 5` - 3.` 5' 
to 3.' 
Reverse primers 5` - 3.` 5' to 3.' 
MRP1 NM_008576. CGTGCTGTCCTGCTTCTC CTTCTGATGTGTCCTCCTTATTC 
MRP3 NM_029600 GGTTATCCAGGCTCAAGAC GCCGTGGAAGGAATAGAAC 
18S* 
GAPDH* 
NR_003278. 
NM_008084. 
TCCGATAACGAACGAGAC 
CCAGTATGACTCCACTCACG 
CTAAGGGCATCACAGACC 
CTCGCTCCTGGAAGATGGTG 
 
*Housekeeping genes used to normalise the expression of target genes. 
 
 
Table 2. Summary of antibodies 
Target  
proteins 
1
st
 antibodies  2
nd
 antibodies 
 
MRP1 A23 (Fernetti et al.,) 2001)  Goat anti-rabbit IgG/HRP (Dacko Lab.) 
MRP3 C18(Santa Cruz Biotech) Donkey anti-goat IgG/HRP (Jackson Lab.) 
α-actin* A2066 (Sigma Aldrich)  Goat anti-rabbit IgG/HRP (Dacko Lab.) 
*Housekeeping protein used to normalise the expression of target proteins. 
 
 
Table 3: Total serum bilirubin (TSB) in WT and hyperbilirubinemic animal 
models 
Animal 
model 
Total serum bilirubin (TSB) mg/dl 
WT mouse 1.6.±.0.53 
β-Thal mouse 5.95 ± 0.75  
NN WT rat 0.33 ± 0.1 
jj Gunn rat 13.83 ± 3.33 
TSB was measured by diazo-reaction in five animals for each group 
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Figure 1: (A) MRP1 mRNA relative expression in the spleen of WT and β-
thalassemic mouse. MRP1 expression was normalised to 18S and GAPDH and 
presented relative to WT controls. (B) MRP1 protein expression was analysed by 
western blot and normalised to α-actin then represented as a ratio. 
 
 
 
Figure 2: (A) MRP1 mRNA relative expression in liver of NN control rat and jj 
Gunn rat. MRP1 expression was normalised to 18S and GAPDH and presented 
relative to NN controls. (B) MRP1 protein expression was analysed by western 
blot and normalised to α-actin then represented as a ratio. 
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Figure 3: (A) MRP3 mRNA relative expression in the spleen of WT and β-
thalassemic mouse. MRP1 expression was normalised to 18S and GAPDH and 
presented relative to WT controls. (B) MRP3 protein expression was analysed by 
western blot and normalised to α-actin then represented as a ratio. 
 
 
 
Figure 4: (A) MRP3 mRNA relative expression in liver of NN control rat and jj 
Gunn rat. MRP1 expression was normalised to 18S and GAPDH and presented 
relative to NN controls. (B) MRP3 protein expression was analysed by western 
blot and normalised to α-actin then represented as a ratio. 
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